+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Biologics Outsourcing Services Market - Forecasts from 2018 to 2023

  • ID: 4542580
  • Report
  • 96 pages
  • Knowledge Sourcing Intelligence LLP
1 of 4


  • Cytovance Biologics
  • Eurofins Scientific SE
  • Lonza Group Ltd.
  • Sartorius AG
  • SGS SA
  • Toxikon, Inc.
  • MORE
The biologics outsourcing services market was valued at US$8.607 billion in 2017 and is projected to expand at a CAGR of 11.84% over the forecast period to reach US$16.838 billion by 2023. The global demand for outsourced biologics is highly driven by need to take initiative for developmental activities by biotechnology industry as biologics have vast scope of R & D and innovation in the field. Biological products often manufactures in-house by bio-technology firms are heat sensitive and highly susceptible to contamination, and hence follow different steps than most of the conventional drugs. And, therefore outsourcing biologics outsourcing services is more competent strategy for these firms. The global biologics outsourcing services market is supported by various factors such as growing demand for outsourcing variety, demand of antibody conjugate, increasing biologics approvals, and others. However, various inhibiting factors such as limited knowledge in the biologics field, complexities in handling biologics, and lack of skilled professionals is likely to impend the market growth during the forecast period.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the biologics outsourcing services value chain. Last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the biologics outsourcing services market.

Major industry players profiled as part of the report are Lonza Group Ltd., Charles River Laboratories, SGS SA, and Thermo Fisher Scientific Inc. among others.


The biologics outsourcing services market has been analyzed through following segments:

By Product:
  • Antibody
  • Recombinant Protein
  • Vaccines
  • Others
By Application:
  • Vaccine & Therapeutics Development
  • Blood and Blood-Related Products Testing
  • Cellular and Gene Therapy
  • Tissue and Tissue-Related Products Testing
  • Stem Cell Research
By Geography:
  • North America
  • United States
  • Canada
  • Mexico
  • Others
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • South Africa
  • Others
  • Asia Pacific
  • Japan
  • Korea
  • China
  • India
  • Others
Note: Product cover images may vary from those shown
2 of 4


  • Cytovance Biologics
  • Eurofins Scientific SE
  • Lonza Group Ltd.
  • Sartorius AG
  • SGS SA
  • Toxikon, Inc.
  • MORE
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2.1. Research Design
2.2. Secondary Sources


4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5.1. Antibody
5.2. Recombinant Protein
5.3. Vaccines
5.4. Others

6.1. Vaccine & Therapeutics Development
6.2. Blood and Blood-Related Products Testing
6.3. Cellular and Gene Therapy
6.4. Tissue and Tissue-Related Products Testing
6.5. Stem Cell Research

7.1. North America
7.1.1. United States
7.1.2. Canada
7.1.3. Mexico
7.1.4. Others
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. United Kingdom
7.3.2. Germany
7.3.3. France
7.3.4. Italy
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. United Arab Emirates
7.4.3. South Africa
7.4.4. Others
7.5. Asia Pacific
7.5.1. Japan
7.5.2. Korea
7.5.3. China
7.5.4. India
7.5.5. Others

8.1. Recent Deals and Investment
8.2. Strategies of Key Players
8.3. Investment Analysis

9.1. Lonza Group Ltd.
9.1.1. Company Overview
9.1.2. Financials
9.1.3. Products and Services
9.1.4. Recent Developments
9.2. Charles River Laboratories
9.2.1. Company Overview
9.2.2. Financials
9.2.3. Products and Services
9.2.4. Recent Developments
9.3. SGS SA
9.3.1. Company Overview
9.3.2. Financials
9.3.3. Products and Services
9.3.4. Recent Developments
9.4. Thermo Fisher Scientific Inc.
9.4.1. Company Overview
9.4.2. Financials
9.4.3. Products and Services
9.4.4. Recent Developments
9.5. WuXi AppTec
9.5.1. Company Overview
9.5.2. Financials
9.5.3. Products and Services
9.5.4. Recent Developments
9.6. Sartorius AG
9.6.1. Company Overview
9.6.2. Financials
9.6.3. Products and Services
9.6.4. Recent Developments
9.7. Cytovance Biologics
9.7.1. Company Overview
9.7.2. Financials
9.7.3. Products and Services
9.7.4. Recent Developments
9.8. Pace Analytical Services, LLC
9.8.1. Company Overview
9.8.2. Financials
9.8.3. Products and Services
9.8.4. Recent Developments
9.9. Toxikon, Inc.
9.9.1. Company Overview
9.9.2. Financials
9.9.3. Products and Services
9.9.4. Recent Developments
9.10. Eurofins Scientific SE
9.10.1. Company Overview
9.10.2. Financials
9.10.3. Products and Services
9.10.4. Recent Developments
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Lonza Group Ltd.
  • Charles River Laboratories
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
  • Sartorius AG
  • Cytovance Biologics
  • Pace Analytical Services, LLC
  • Toxikon, Inc.
  • Eurofins Scientific SE
Note: Product cover images may vary from those shown
5 of 4

The research study is based on the publisher's proprietary research model. The process involves sourcing of information from various industry experts, key professionals, decision-makers and various other stakeholders along with the validation of the responses received from the vast in-house database and premium paid databases. Publicly available sources were also taken into consideration for the final market estimates and forecast for the segments and sub-segments.

The first phase of the research process is the identification of key industry leaders, experts, decision-makers and C-level executives and then conducting interviews and surveys to gain vital insights about the market. Simultaneously, extensive secondary research is done, and key secondary data is collected as part of this process. This secondary data is collected from various databases, industry journals, whitepapers, company annual reports, research publications, and other paid data sources and relevant literature. Company profiles which include strategies, new product developments, recent investments, major products and services, financials and business plans are sourced from the annual reports, SEC filings, industry associations to preserve the quality of the information being displayed. The findings from both the primary and the secondary research process combined go under further processing for market breakdown and forecasting.

The last phase is providing intelligence in the form of presentation, charts, graphics and other different formats helping the clients in a faster and efficient understanding of the market. Under this phase complete market engineering is involved which includes analyzing the collected data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting. The publisher has developed their market forecasting methodology that, in addition to the main market values, also takes into account other macroeconomic factors (global or local) that might have some bearing on the market under study. Taking all the necessary data, a robust forecast is developed using an algorithm that involves both static (multivariate) as well as dynamic (time-series) regression analysis. Special care is taken to make sure their algorithm passes the necessary statistical tests, and the mean prediction for future years obtained is reliable with a very high confidence level. Following data validation, the analysts begin to write the report presenting insights with the help of charts, graphs, and tables.